PRR7 is a transmembrane adaptor protein expressed in activated T cells involved in regulation of T cell receptor signaling and apoptosis
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
21460222
PubMed Central
PMC3103341
DOI
10.1074/jbc.m110.175117
PII: S0021-9258(20)51040-5
Knihovny.cz E-resources
- MeSH
- Adaptor Proteins, Signal Transducing biosynthesis genetics immunology MeSH
- Amino Acid Motifs MeSH
- Apoptosis drug effects physiology MeSH
- Caco-2 Cells MeSH
- Antigens, CD biosynthesis genetics immunology MeSH
- Antigens, Differentiation, T-Lymphocyte biosynthesis genetics immunology MeSH
- Phosphorylation drug effects physiology MeSH
- HEK293 Cells MeSH
- Interleukin-2 biosynthesis genetics immunology MeSH
- Ionophores pharmacology MeSH
- Ionomycin pharmacology MeSH
- Jurkat Cells MeSH
- Carcinogens pharmacology MeSH
- Rats MeSH
- Lectins, C-Type biosynthesis genetics immunology MeSH
- Humans MeSH
- Proto-Oncogene Proteins c-jun genetics immunology metabolism MeSH
- Receptors, Antigen, T-Cell genetics immunology metabolism MeSH
- Gene Expression Regulation physiology MeSH
- T-Lymphocytes immunology metabolism MeSH
- Protein Structure, Tertiary MeSH
- Tetradecanoylphorbol Acetate pharmacology MeSH
- U937 Cells MeSH
- Calcium Signaling drug effects physiology MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Adaptor Proteins, Signal Transducing MeSH
- Antigens, CD MeSH
- CD69 antigen MeSH Browser
- Antigens, Differentiation, T-Lymphocyte MeSH
- IL2 protein, human MeSH Browser
- Interleukin-2 MeSH
- Ionophores MeSH
- Ionomycin MeSH
- Carcinogens MeSH
- Lectins, C-Type MeSH
- Proto-Oncogene Proteins c-jun MeSH
- Receptors, Antigen, T-Cell MeSH
- Tetradecanoylphorbol Acetate MeSH
Transmembrane adaptor proteins (TRAPs) are important organizers and regulators of immunoreceptor-mediated signaling. A bioinformatic search revealed several potential novel TRAPs, including a highly conserved protein, proline rich 7 (PRR7), previously described as a component of the PSD-95/N-methyl-d-aspartate receptor protein complex in postsynaptic densities (PSD) of rat neurons. Our data demonstrate that PRR7 is weakly expressed in other tissues but is readily up-regulated in activated human peripheral blood lymphocytes. Transient overexpression of PRR7 in Jurkat T cell line led to gradual apoptotic death dependent on the WW domain binding motif surrounding Tyr-166 in the intracellular part of PRR7. To circumvent the pro-apoptotic effect of PRR7, we generated Jurkat clones with inducible expression of PRR7 (J-iPRR7). In these cells acute induction of PRR7 expression had a dual effect. It resulted in up-regulation of the transcription factor c-Jun and the activation marker CD69 as well as enhanced production of IL-2 after phorbol 12-myristate 13-acetate (PMA) and ionomycin treatment. On the other hand, expression of PRR7 inhibited general tyrosine phosphorylation and calcium influx after T cell receptor cross-linking by antibodies. Moreover, we found PRR7 constitutively tyrosine-phosphorylated and associated with Src. Collectively, these data indicate that PRR7 is a potential regulator of signaling and apoptosis in activated T cells.
See more in PubMed
Simeoni L., Kliche S., Lindquist J., Schraven B. (2004) Curr. Opin. Immunol. 16, 304–313 PubMed
Zhang W., Trible R. P., Samelson L. E. (1998) Immunity 9, 239–246 PubMed
Brdiĉka T., Cerný J., Horejŝí V. (1998) Biochem. Biophys. Res. Commun. 248, 356–360 PubMed
Brdicka T., Pavlistová D., Leo A., Bruyns E., Korínek V., Angelisová P., Scherer J., Shevchenko A., Hilgert I., Cerný J., Drbal K., Kuramitsu Y., Kornacker B., Horejsí V., Schraven B. (2000) J. Exp. Med. 191, 1591–1604 PubMed PMC
Kawabuchi M., Satomi Y., Takao T., Shimonishi Y., Nada S., Nagai K., Tarakhovsky A., Okada M. (2000) Nature 404, 999–1003 PubMed
Brdicka T., Imrich M., Angelisová P., Brdicková N., Horváth O., Spicka J., Hilgert I., Lusková P., Dráber P., Novák P., Engels N., Wienands J., Simeoni L., Osterreicher J., Aguado E., Malissen M., Schraven B., Horejsí V. (2002) J. Exp. Med. 196, 1617–1626 PubMed PMC
Janssen E., Zhu M., Zhang W., Koonpaew S., Zhang W. (2003) Nat. Immunol. 4, 117–123 PubMed
Brdicková N., Brdicka T., Angelisová P., Horváth O., Spicka J., Hilgert I., Paces J., Simeoni L., Kliche S., Merten C., Schraven B., Horejsí V. (2003) J. Exp. Med. 198, 1453–1462 PubMed PMC
Hur E. M., Son M., Lee O. H., Choi Y. B., Park C., Lee H., Yun Y. (2003) J. Exp. Med. 198, 1463–1473 PubMed PMC
Zhu M., Janssen E., Leung K., Zhang W. (2002) J. Biol. Chem. 277, 46151–46158 PubMed
Marie-Cardine A., Kirchgessner H., Bruyns E., Shevchenko A., Mann M., Autschbach F., Ratnofsky S., Meuer S., Schraven B. (1999) J. Exp. Med. 189, 1181–1194 PubMed PMC
Bruyns E., Marie-Cardine A., Kirchgessner H., Sagolla K., Shevchenko A., Mann M., Autschbach F., Bensussan A., Meuer S., Schraven B. (1998) J. Exp. Med. 188, 561–575 PubMed PMC
Liu Y., Zhang W. (2008) J. Leukoc. Biol. 84, 842–851 PubMed PMC
Horejsí V. (2004) Immunol. Lett. 92, 43–49 PubMed
Horejsí V., Otáhal P., Brdicka T. (2010) FEBS J. 277, 4383–4397 PubMed
Fuller D. M., Zhang W. (2009) Immunol. Rev. 232, 72–83 PubMed PMC
Koelsch U., Schraven B., Simeoni L. (2008) J. Immunol. 181, 5930–5939 PubMed
Murata Y., Doi T., Taniguchi H., Fujiyoshi Y. (2005) Biochem. Biophys. Res. Commun. 327, 183–191 PubMed
Krogh A., Larsson B., von Heijne G., Sonnhammer E. L. (2001) J. Mol. Biol. 305, 567–580 PubMed
Hobbs S., Jitrapakdee S., Wallace J. C. (1998) Biochem. Biophys. Res. Commun. 252, 368–372 PubMed
Lessard J., Aicha S. B., Fournier A., Calvo E., Lavergne E., Pelletier M., Labrie C. (2007) Prostate 67, 808–819 PubMed
Qiao L., Schürmann G., Betzler M., Meuer S. C. (1991) Gastroenterology 101, 1529–1536 PubMed
Fraser J. D., Goldsmith M. A., Weiss A. (1989) Proc. Natl. Acad. Sci. U.S.A. 86, 7133–7137 PubMed PMC
Otáhal P., Angelisová P., Hrdinka M., Brdicka T., Novák P., Drbal K., Horejsí V. (2010) J. Immunol. 184, 3689–3696 PubMed
Wan J., Roth A. F., Bailey A. O., Davis N. G. (2007) Nat. Protoc. 2, 1573–1584 PubMed
Finn R. D., Mistry J., Tate J., Coggill P., Heger A., Pollington J. E., Gavin O. L., Gunasekaran P., Ceric G., Forslund K., Holm L., Sonnhammer E. L., Eddy S. R., Bateman A. (2010) Nucleic Acids Res. 38, D211–D222 PubMed PMC
Chen H. I., Sudol M. (1995) Proc. Natl. Acad. Sci. U.S.A. 92, 7819–7823 PubMed PMC
Saras J., Heldin C. H. (1996) Trends Biochem. Sci. 21, 455–458 PubMed
Brannetti B., Helmer-Citterich M. (2003) Nucleic Acids Res. 31, 3709–3711 PubMed PMC
Round J. L., Tomassian T., Zhang M., Patel V., Schoenberger S. P., Miceli M. C. (2005) J. Exp. Med. 201, 419–430 PubMed PMC
Bonifacino J. S., Traub L. M. (2003) Annu. Rev. Biochem. 72, 395–447 PubMed
Jadot M., Canfield W. M., Gregory W., Kornfeld S. (1992) J. Biol. Chem. 267, 11069–11077 PubMed
Gao M., Labuda T., Xia Y., Gallagher E., Fang D., Liu Y. C., Karin M. (2004) Science 306, 271–275 PubMed
Jain J., Valge-Archer V. E., Rao A. (1992) J. Immunol. 148, 1240–1250 PubMed
Castellanos M. C., Muñoz C., Montoya M. C., Lara-Pezzi E., López-Cabrera M., de Landázuri M. O. (1997) J. Immunol. 159, 5463–5473 PubMed
Roose J. P., Mollenauer M., Ho M., Kurosaki T., Weiss A. (2007) Mol. Cell. Biol. 27, 2732–2745 PubMed PMC
Krammer P. H., Arnold R., Lavrik I. N. (2007) Nat. Rev. Immunol. 7, 532–542 PubMed
Normal Development and Function of T Cells in Proline Rich 7 (Prr7) Deficient Mice
The transmembrane region is responsible for targeting of adaptor protein LAX into "heavy rafts"